                               SEQUENCE LISTING

<110> CALLIDUS BIOPHARMA, INC.
 
<120> METHODS FOR COUPLING TARGETING PEPTIDES ONTO RECOMBINANT 
      LYSOSOMAL ENZYMES FOR IMPROVED TREATMENTS OF LYSOSOMAL 
      STORAGE DISEASES

<130> CALL-0048

<140> PCT/US2013/071994
<141> 2013-11-26

<150> 61/729,857
<151> 2012-11-26

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 282
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
atgggcagcc accaccacca tcatcaccac cacactagtg ccggcgagaa tctgtacttt       60

cagggcggtg gtggtagcgg cggtggtggt agccgtaccc tgtgtggtgg cgaattggtt      120

gatacgctgc aattcgtctg tggtgaccgc ggtttcctgt tctctcgtcc ggcgtcccgc      180

gtgagccgtc gcagccgtgg tatcgttgaa gagtgctgtt ttcgtagctg cgacctggct      240

ctgctggaaa cctattgcgc gaccccggca cgtagcgagt ga                         282


<210> 2
<211> 72
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Arg Thr Leu Cys Gly Gly 
1               5                   10                  15      


Glu Leu Val Asp Thr Leu Gln Phe Val Cys Gly Asp Arg Gly Phe Leu 
            20                  25                  30          


Phe Ser Arg Pro Ala Ser Arg Val Ser Arg Arg Ser Arg Gly Ile Val 
        35                  40                  45              


Glu Glu Cys Cys Phe Arg Ser Cys Asp Leu Ala Leu Leu Glu Thr Tyr 
    50                  55                  60                  


Cys Ala Thr Pro Ala Arg Ser Glu 
65                  70          


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Gly Gly Gly Ser Gly Gly Gly 
1               5               


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      8xHis tag

<400> 4
His His His His His His His His 
1               5               


